Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

McMaster; 3:30 PM • Armenian foreign minister speaks on Atlantic Council online event on the Nagorno-Karabakh conflict - Armenian Foreign Minister Mnatsakanyan speaks on Atlantic Council Eurasia Center online event, discussing his talks with Secretary of State Mike Pompeo, Armenia's position on the Nagorno

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

y McMaster; 3:30 PM * Armenian foreign minister speaks on Atlantic Council online event on the Nagorno-Karabakh conflict — Armenian Foreign Minister Mnatsakanyan speaks on Atlantic Council Eurasia Center online event, discussing his talks with Secretary of State Mike Pompeo, Armenia's position on the Nagorno-

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

McMaster; 3:30 PM • Armenian foreign minister speaks on Atlantic Council online event on the Nagorno-Karabakh conflict - Armenian Foreign Minister Mnatsakanyan speaks on Atlantic Council Eurasia Center online event, discussing his talks with Secretary of State Mike Pompeo, Armenia's EFTA00148481 position